跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
HIDROXOCOBALAMINA BASI 1 MG/ML SOLUCION INYECTABLE
Approved
STANDARD
HIDROXOCOBALAMINA BASI 1 MG/ML SOLUCION INYECTABLE
Laboratorios Basi Industria Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 23, 2023
Approval ID
0a16debff9e117b3
Company
Laboratorios Basi Industria Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
0a16debff9e117b3
Drug Cima Aemps Name
HIDROXOCOBALAMINA BASI 1 MG/ML SOLUCION INYECTABLE
Register Number
88743
Holder Company Name
Laboratorios Basi Industria Farmaceutica S.A.
Marketing Company Name
Laphysan S.A.U.
Authorization Date
2023-03-23
Dosage Form
SOLUCIÓN INYECTABLE
Dose
1 mg/ml
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Basi Industria Farmaceutica S.A.
Active Ingredients
HIDROXOCOBALAMINA HIDROCLORURO
1,027 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 23, 2023
Approval ID
0a16debff9e117b3
Type
Standard
Back to CIMA-AEMPS Approvals
HIDROXOCOBALAMINA BASI 1 MG/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
